MedPath
HSA Approval

ENAPRIL- 5 TABLET 5 mg

SIN11572P

ENAPRIL- 5 TABLET 5 mg

ENAPRIL- 5 TABLET 5 mg

June 21, 2001

APOTHECA MARKETING PTE LTD

APOTHECA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPOTHECA MARKETING PTE LTD
Licence HolderAPOTHECA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C09AA02

enalapril

Manufacturer Information

APOTHECA MARKETING PTE LTD

INTAS PHARMACEUTICALS LTD

Intas Pharmaceuticals Ltd.

Active Ingredients

ENALAPRIL MALEATE

5.000 mg

Enalapril

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ENAPRIL- 5 TABLET 5 mg - HSA Approval | MedPath